Jamp-Rabeprazol recall in Canada: tablets may be incorrect weight
In plain language
This recall involves Jamp-Rabeprazol 10mg and 20mg tablets sold in Canada. They are being recalled because some tablets may be overweight or underweight. Stop using the product and consult your healthcare provider.
What to do
- Stop using the product immediately.
- Check the lot numbers to see if your product is affected.
- Consult your healthcare provider before stopping use or for any health concerns.
- Contact the recalling firm if you have questions.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Jamp-Rabeprazol 10mg
Lot: EG24RJA002
Jamp-Rabeprazol 20mg
Lot: EG23RJC003, EG23RJC006, EG23RJC007, EG23RJC009, EG23RJC010, EG23RJD001, EG23RJD002, EG23RJD003, EG23RJD004, EG24RJD001
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the lot number
Lot numbers identify specific production batches.
Affected lots: EG23RJC003, EG23RJC006, EG23RJC007, EG23RJC009, EG23RJC010, EG23RJD001, EG23RJD002, EG23RJD003, EG23RJD004, EG24RJD001, EG24RJA002
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
This recall involves Jamp-Rabeprazol 10mg and 20mg tablets sold in Canada. They are being recalled because some tablets may be overweight or underweight. Stop using the product and consult your healthcare provider.
What should consumers do?
Stop using the product immediately. Check the lot numbers to see if your product is affected. Consult your healthcare provider before stopping use or for any health concerns. Contact the recalling firm if you have questions.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
A potential safety risk has been identified with this product. Stop using it immediately and follow the instructions in the official recall notice.
When was this product recalled?
This product was recalled on August 20, 2024.
Is the JAMP brand affected by this recall?
Yes, JAMP products are affected by this recall. This recall involves Jamp-Rabeprazol 10mg and 20mg tablets sold in Canada. They are being recalled because some tablets may be overweight or underweight. Stop using the product and consult your healthcare provider.